Risk Assessment and Risk Management Plan for DIR 116
Limited and controlled release of genetically modified live viral vaccines against prostate cancer
Applicant: PPD Australia Pty Ltd
The Office of the Gene Technology Regulator
Thank you for taking the time to provide feedback. It will be used to make improvements to this website.